Schaftoside inhibits 3CLpro and PLpro of SARS-CoV-2 virus and regulates immune response and inflammation of host cells for the treatment of COVID-19.
Yi Y, Zhang M, Xue H, Yu R, Bao YO, Kuang Y, Chai Y, Ma W, Wang J, Shi X, Li W, Hong W, Li J, Muturi E, Wei H, Wlodarz J, Roszak S, Qiao X, Yang H, Ye M.
Yi Y, et al. Among authors: ye m.
Acta Pharm Sin B. 2022 Nov;12(11):4154-4164. doi: 10.1016/j.apsb.2022.07.017. Epub 2022 Aug 9.
Acta Pharm Sin B. 2022.
PMID: 35968270
Free PMC article.